
Anasens is a highly disruptive start-up (deep tech) developing an innovative quantitative and connected molecular detection platform for blood or saliva analysis, at home or at a point of service, in less than 5 minutes. This new technology from the lab of Prof Vallée-Bélisle, Chair of Research from Canada in Bioengineering and Bio-nanotechnology, has been developed at UdeM for more than 10 years and for more than 6 years in collaboration with international industry leaders.
Annual Revenue$1M to $5M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.